Mega-cap tech is pushing the S&P 500 higher as AI boosts profits despite rates and inflation. Click here to read what ...
Researchers identify GPNMB as a driver of Parkinson’s disease spread and demonstrate that monoclonal antibodies can block its activity to slow neurodegeneration.
Ready Capital (RC) faces falling book value, negative cash flow, and rising delinquencies. Read more macro analysis here.
According to Nuvama Alternative & Quantitative Research, the six-month lock-in for Lenskart ends today, with as many as 1,047 ...
Alpha Cognition Inc. (ACOG: NASDAQ) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today reported ...
Monoclonal antibodies can block a key immune-related protein that drives the spread of brain cell damage in Parkinson's ...
The Library of Congress revealed this year's list of 25 recordings to be preserved for future generations on the National ...
Tech companies are constantly on the hunt for new customers, and Cash App, the fintech company owned by Jack Dorsey’s Block, believes it has found a promising new demographic: children. The company, ...